Safe and Effective Pain Management When Ethically Prescribing Opioids and Other Controlled Substances to Dental Patients


Friday, November 19, 2021   Live Interactive Webinar 8:30 AM - 12:45 PM CST



This presentation combines all dentists' controlled substance CE requirements into a single 4-hour course. The Texas State Board Dental Examiners will count the 2 hours of CE required for DEA permit holders (RULE §111.1 (b)) towards the 4 hours of CE required for all dentists providing direct patient care starting January 1, 2021 (RULE §104.1 (2)(B)). Upon completing this 4-hour course, you will meet required hours for both RULE §111.1 (b) and  RULE §104.1 (2)(B).

Dr. Jeske will provide an in-depth review of the clinical pharmacologic characteristics of opioids and other controlled substances utilized in pain control, including indications, contraindications, adverse effects, and drug-drug interactions regarding beneficial and adverse drugs. This presentation emphasizes safe and effective dosing and the proper dose regimens in the preoperative and postoperative care settings. Attendees can also expect to learn more about medicolegal and ethical considerations, including reasonable standards of care to be applied when prescribing controlled substances.



Upon completion of the course, the dentist will be able to describe and apply the following during direct patient care:

  • Selecting specific opioids for dental pain management
  • Recognize the indications and contraindications for specific opioids and other controlled substances used in pain management
  • Recognize the adverse effects of pain-control medication
  • Avoid adverse drug-drug interactions and utilize the beneficial drug-drug interaction during patient management and treatment
  • Use pre-emptive therapies to optimize intraoperative and postoperative pain control 
  • Identify drug-seeking behavior in patients
  • Medicolegal and ethical considerations in dental pain management
  • Effectively communicate with patients about controlled substances to achieve the best pain-management outcomes and avoid adverse events.


Sign Up Today!


TDA Members Sign Up Here


As a courtesy, please register in advance to receive presentation links, course handouts and other timely information. For your convenience, registration will close 24 hours prior to course date.

Live Interactive Webinars are considered as in-classroom setting CE hours by the Texas State Board of Dental Examiners.

Continuing education credits awarded for participation in this Live Interactive Webinar may not apply as in person/ in-classroom CE hours towards license renewal in all states. It is the responsibility of each participant to verify the requirements of his/her state licensing board(s).

TSBDE Rules & Regulations

Effective January 1, 2021, TSDBE RULE §104.1 (2)(B) requires that licensed dentists whose practice includes direct patient care must complete not less than 2 hours of continuing education annually, and not less than 4 hours for each biennial renewal, regarding safe and effective pain management related to the prescription of opioids and other controlled substances. These 4 hours may be used to satisfy the 16-hour technical and scientific requirement. The courses taken to satisfy the safe and effective pain management requirement must include education regarding (i) reasonable standards of care; (ii) the identification of drug-seeking behavior in patients; and (iii) effectively communicating with patients regarding the prescription of an opioid or other controlled substance.

Effective September 1, 2020, RULE RULE §111.1 (b) requires that dentists permitted to prescribe controlled substances must complete 2 hours of continuing education related to approved procedures of prescribing and monitoring controlled substances. These 2 hours of continuing education may be used to satisfy the recordkeeping continuing education requirements of §104.1 of this title (relating to Requirement).

About Our Speaker


Arthur H. Jeske, DMD, PhDis the associate dean for strategic planning and a professor in the Department of General Dentistry and Dental Public Health at The University of Texas School of Dentistry at Houston. He earned his PhD in pharmacology and DMD from the Medical College of Georgia. He is a member of the American Dental Association (ADA), Texas Dental Association, and Greater Houston Dental Society and is a fellow of the International College of Dentistry and the American College of Dentistry. Dr. Jeske chaired the ADA's Council on Scientific Affairs in 2004 and has authored numerous articles on the use of drugs in dentistry. He is currently editor-in-chief of Mosby's Dental Drug Reference and an editor of Contemporary Dental Pharmacology.



Tuition | Course Fee

Live Interactive Webinar Presentation:
$180 - Dentist

Course fee is due at time of registration.

Credit Hours

340 Prescribing Medication Management (Controlled Substance) - Lecture: Hours - 2
340 Prescribing Med. Management (Controlled Substance| Record Keeping) - Lecture: Hours - 2



This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Recognition Program (ADA CERP) through joint efforts between The University of Texas School of Dentistry at Houston — PACE Center and the Texas Dental Association.



Webinar Link Opens:
8:00 AM CST

8:30 AM to 12:45 PM CST

Live Interactive Webinar Location:
Virtual CDE | Live Interactive Webinar

Share This

Contact Us
UTHealth School of Dentistry
PACE Center, Continuing Dental Education
7500 Cambridge St., Suite 6152
Houston, TX 77054
Ph: 713-486-4028
Fax: 713-486-4037